Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients

M.M. Vellinga, J.A. Castelijns, F. Barkhof, B.M.J. Uitdehaag, C.H. Polman

Research output: Contribution to journalArticleAcademicpeer-review

133 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1150-1151
JournalNeurology
Volume70
Issue number13 Pt 2
DOIs
Publication statusPublished - 2008

Cite this